WHO approves emergency use of Serum Institute's Covid-19 vaccine Covovax

17 December,2021 08:41 PM IST |  Geneva  |  ANI

WHO approval is a prerequisite for being on the COVAX drug list, as well as for international procurement

This image has been used for representation purpose


The World Health Organization (WHO) said it had approved the Covovax coronavirus vaccine, which is manufactured by the Serum Institute of India under license from US company Novavax, for emergency use.

"Today, the World Health Organization issued and emergency use listing (EUL) for NVX-CoV2373, expanding the basket of WHO-validated vaccines against the SARS-CoV-2 virus. The vaccine, named CovovaxTM, is produced by the Serum Institute of India under licence from Novavax and is part of the COVAX facility portfolio, giving a much-needed boost to ongoing efforts to vaccinate more people in lower-income countries," the global health body said in a statement.

WHO approval is a prerequisite for being on the COVAX drug list, as well as for international procurement.

Also read: Serum Institute working to develop Covid-19 vaccine booster shot which is effective against Omicron: Poonawala

According to the statement, Covovax was assessed under the WHO EUL procedure based on the review of data on quality, safety and efficacy, a risk management plan, programmatic suitability, and manufacturing site inspections carried out by the Drugs Controller General of India.

The Technical Advisory Group for Emergency Use Listing (TAG-EUL), convened by WHO and made up of experts from around the world, has determined that the vaccine meets WHO standards for protection against COVID-19, that the benefit of the vaccine far outweighs any risks, and that the vaccine can be used globally.

Covavax is the Indian version of the Novavax vaccine brought in India by the Serum Institute of India for children.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!
world health organization Omicron Coronavirus
Related Stories